课题基金 / 基金详情

Sodium-glucose co-transporter 2 inhibitors and bladder cancer - a causal association or detection bias? An international multicenter cohort study.

Sodium-glucose co-transporter 2 inhibitors and bladder cancer - a causal association or detection bias? An international multicenter cohort study.
钠-葡萄糖协同转运蛋白 2 抑制剂与膀胱癌 - 因果关系还是检测偏倚？
批准号：
396360
负责人：
Abrahami Devin
金额：
$10.93万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-10-01 至 2021-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=396360&lang=en
关键词：
Bladder Cancer Health Outcomes International Multicenter Cohort Study Pharmacoepidemiology Propensity Score Type 2 Diabetes

项目摘要

项目成果

Abrahami Devin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 2 diabetes is one of the fastest growing diseases in Canada, with approximately 60,000 new patients diagnosed each year. In recent years, there have been major advancements in the treatment of type 2 diabetes with the discovery of new drug classes, s
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The comparative effectiveness and safety of four second-line antihyperglycemic drugs in type 2 diabetes mellitus: an international multi-centre cohort study
海外基金